Agatolimod Uses, Dosage, Side Effects and more
Agatolimod is under investigation in clinical trial NCT00471471 (Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery).
| Trade Name | Agatolimod |
| Generic | Agatolimod |
| Agatolimod Other Names | Agatolimod |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
